Location: Home
  • search
  • go
  • Relate News
  • 10/17/2024Hutchmed Announces Positive Results from Phase II SAVANNAH Trial for L...
  • 10/17/2024NMPA Holds National Drug Distribution Supervision Work Conference
  • 10/16/2024Eli Lilly Expands Innovation Centers to Beijing with New Research Faci...
  • 10/16/2024TenNor Announces CNY 300M+ Financing to Support Development and Comme...
  • 10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...
  • 10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab
  • 10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China
  • 10/16/2024Akeso Launches Phase 1/2 Trial of AK129 and AK117
  • 10/16/2024Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...
  • 10/16/2024Hinova Pharma Receives IND Approval for PROTAC Candidate HP568 in Chin...
  • 10/16/2024Novartis to Negotiate NRDL Inclusion of siRNA Cholesterol-Reduction Dr...
  • 10/16/2024NHSA Issues the Notice on Regulating the Management of Externally-fill...
  • 10/16/2024China's New Policies On Foreign Investment In Healthcare And Biotechno...
  • 10/16/2024China Biopharma Tracker – Q3 2024 (PharmaDJ)
  • 10/16/2024Understanding the NewCo Model: A Trending Approach of Chinese Pharmace...
  • 10/16/2024As U.S. Efforts Stall, China Pushes Ahead with CRISPR Treatments for M...
  • 10/15/2024AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
  • 10/15/2024Wuhan iRegene Completes Over CNY 100M Series B Financing
  • 10/15/2024Akeso Secures $250M to Propel Global Expansion of Its Innovative Drug...
  • 10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
  • 10/15/2024Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
  • 10/15/2024China Expands Health Silk Road to Dominate Africa's Pharmaceutical Mar...
  • 10/15/2024Dizal's Sunvozertinib Granted BTD in China for Treatment-Naive EGFR Ex...
  • 10/15/2024China Solicits Comments on Draft Compliance Guidelines for Pharmaceuti...
  • 10/15/2024NMPA Issues the Application Procedures and Dossier Requirements for th...
  • 10/15/2024CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
  • 10/15/2024Review of Online Drug Sales Growth in China 2021-2023
  • 10/11/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...
  • 10/11/2024NMPA Announces Package Insert Revision of Sodium Gluconate Injection P...
  • 10/11/2024CDE Solicits Comments on the Proposed Technical Guidelines for Model-I...
  • Page:45/774 Total number of articles:23207: [First][<<] [43] [44] [45] [46] [47] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group